Evidence map›Paper›PMID 42109606›Full record

ArticleImmune network2026

Cigarette Smoke Induces the Pro-inflammatory Response of Lung Macrophages via Activation of the IL-33/ST2-Dependent Pathway.

Yujin Kim, Yosep Mo, Ji-Young Bang, Jihyun Kim, In-Gu Lee, Hye Young Kim, Hye-Ryun Kang

Abstract read
In one paragraph

Article in Immune network, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yujin KimInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0002-9838-5441
Yosep MoInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0003-0095-4464
Ji-Young BangInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0001-6859-4595
Jihyun KimInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0003-1222-0345
In-Gu LeeInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0001-6157-5631
Hye Young KimInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0001-5978-512X
Hye-Ryun KangInstitute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.ORCID https://orcid.org/0000-0002-2317-4201

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cigarette smoke broadly affects the immune system, but the mechanisms by which it disrupts lung innate immunity and impairs macrophage-mediated homeostasis in healthy individuals remain unclear. This study investigates airway inflammation induced by chronic cigarette smoke extract (CSE) exposure by profiling pulmonary macrophages. CSE was generated by bubbling smoke from ten Marlboro cigarettes into 10 ml PBS to obtain 100% CSE, and C57BL/6 mice received 10% CSE intranasally 3 times per week for 4 wk. Chronic CSE exposure induced neutrophilic airway inflammation and augmented pulmonary Th17 and Th1 responses. Among macrophage subsets, CSE exposure promoted the expansion of CD11c

Indexed as

Cigarette smokingIL-33Innate immune responseInterleukin 1 receptor-like 1Macrophages

Identifiers

PMID42109606
PMCPMC13150428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.